The data suggest that the analyzed HNSCC tumors are richly populated by tumor cells expressing both MHC-I (~95%) and MHC-II (~70%) as well as PD-L1 (~20%). The gene discussed is CD274; the disease is head and neck squamous cell carcinoma.